Merlin Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $605K | Sell |
8,879
-46
| -0.5% | -$3.14K | 1.81% | 32 |
|
|
2023
Q4 | $559K | Sell |
8,925
-167
| -2% | -$10.5K | 1.79% | 33 |
|
|
2023
Q3 | $413K | Buy |
9,092
+290
| +3% | +$13.2K | 1.54% | 37 |
|
|
2023
Q2 | $494K | Buy |
8,802
+1,517
| +21% | +$85.2K | 1.67% | 35 |
|
|
2023
Q1 | $330K | Buy |
7,285
+476
| +7% | +$21.5K | 1.2% | 45 |
|
|
2022
Q4 | $277K | Buy |
6,809
+754
| +12% | +$30.7K | 0.68% | 63 |
|
|
2022
Q3 | $396K | Buy |
+6,055
| New | +$396K | 0.92% | 48 |
|